| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 26,483 | 24,916 | 24,439 | 24,896 | | Cost of Revenue | 4,328 | 4,903 | 5,327 | 5,764 | | | Gross Profit |
-
| 20,014 | 19,112 | 19,132 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 12,273 | 12,423 | 11,098 | 11,201 | | Non Recurring | (206) | 206 |
-
|
-
| | Others | 3,527 | 4,861 | 4,373 | 4,728 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,523 | 3,641 | 3,202 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,562 | 2,523 | 3,641 | 3,202 | | Interest Expense | 4,374 | 4,114 | 3,699 | 4,026 | | Income Before Tax | 2,188 | (1,591) | (58) | (824) | | Income Tax Expense | 563 | (831) | (294) | (419) | | Minority Interest | (248) | 151 | (151) | 74 | | | | Net Income From Continuing Ops | 1,625 | (608) | 84 | (331) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 276 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,377 | (608) | 84 | (55) | | Preferred Stock And Other Adjustments | (819) | (1,298) | (696) | (446) | | | Net Income Applicable To Common Shares | $558 | ($1,906) | ($611) | ($501) |
|
0.11% Nasdaq 
0.01%
Income Statement
